News
The team from Tel Aviv University developed a vaccine to combat the bacterium that causes the black plague, using the same ...
16h
The Times of Israel on MSNIn first, Israeli researchers develop mRNA jab against antibiotic-resistant bacteriumScientists from Tel Aviv University and the Israel Institute of Biological Research say their vaccine uses lipid ...
The elephant vaccine closely resembles other mRNA vaccines made for humans. mRNA packed in lipid nanoparticles carries ...
Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform ...
Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 ...
In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of ...
The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
NPR's Pien Huang speaks with pediatrician Alexandra Cvijanovich and Professor Jason L. Schwartz about trying to shore up trust about vaccines.
StockStory.org on MSN3d
Why Moderna (MRNA) Stock Is Up TodayShares of biotechnology company Moderna (NASDAQ:MRNA) jumped 3.8% in the morning session after the U.S. Food and Drug ...
The U.S. Food and Drug Administration has granted full approval for Moderna's MRNA.O COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, ...
Moderna Inc. jumped by 8.83 percent on Tuesday to close at $32.54 apiece as investor sentiment was boosted by a lawsuit filed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results